Assessment of Nanosuspension Formulation for Intranasal Administration.
| Publicado en: | Pharmaceutical Technology Vol. 44; no. 9; pp. 36 - 44 |
|---|---|
| Autores principales: | , , , , , |
| Formato: | Journal Article |
| Publicado: |
MJH Life Sciences
Sep2020
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=145618816&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 145618816 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 15432521 4FK jtl: Pharmaceutical Technology issn: 15432521 maglogo: N pubinfo: dt: Sep2020 vid: 44 iid: 9 pid: 54670 pub: MJH Life Sciences place: Cranbury, New Jersey artinfo: ui: 145618816 145618816 ppf: 36 ppct: 8 formats: fmt: @attributes: type: P tig: atl: Assessment of Nanosuspension Formulation for Intranasal Administration. aug: au: Zode, Sandeep S. Patil, Rajesh Gupta, Piyush Jaladi, Rajasekhar Gautam, Anirudh Raghuvanshi, Rajeev affil: PhD at the National Institute of Pharmaceutical Education and Research, Department of Pharmaceutics, in Punjab, India sug: pubtype: Trade Publication doctype: Journal Article ougenre: Article ab: language: English refInfo: holdings: @attributes: islocal: N |
|---|